ArticleDiabetes, obesity & metabolism2023

iGlarLixi versus basal plus Rapid-Acting insulin in adults with type 2 diabetes advancing from basal insulin therapy: The SoliSimplify Real-World study.

Rory J McCrimmon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.